Literature DB >> 16354114

Hypericin-mediated photocytotoxic effect on HT-29 adenocarcinoma cells is reduced by light fractionation with longer dark pause between two unequal light doses.

Veronika Sacková1, Lucia Kuliková, Jaromír Mikes, Ján Kleban, Peter Fedorocko.   

Abstract

The present study demonstrates the in vitro effect of hypericin-mediated PDT with fractionated light delivery. Cells were photosensitized with unequal light fractions separated by dark intervals (1 or 6 h). We compared the changes in viability, cell number, survival, apoptosis and cell cycle on HT-29 cells irradiated with a single light dose (12 J/cm(2)) to the fractionated light delivery (1 + 11 J/cm(2)) 24 and 48 h after photodynamic treatment. We found that a fractionated light regime with a longer dark period resulted in a decrease of hypericin cytotoxicity. Both cell number and survival were higher after light sensitization with a 6-h dark interval. DNA fragmentation occurred after a single light-dose application, but in contrast no apoptotic DNA formation was detected with a 6-h dark pause. After fractionation the percentage of cells in the G1 phase of the cell cycle was increased, while the proportion of cells in the G2 phase decreased as compared to a single light-dose application, i.e. both percentage of cells in the G1 and G2 phase of the cell cycle were near control levels. We presume that the longer dark interval after the irradiation of cells by first light dose makes them resistant to the effect of the second illumination. These findings confirm that the light application scheme together with other photodynamic protocol components is crucial for the photocytotoxicity of hypericin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16354114     DOI: 10.1562/2005-05-05-RA-514

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  2 in total

1.  Effect of intermittency factor on singlet oxygen and PGE2 formation in azulene-mediated photodynamic therapy: A preliminary study.

Authors:  Teerasak Damrongrungruang; Sujaree Phiphitaporn; Nuttakul Salacheep; Chonlada Sritragool; Aroon Teerakapong; Kittipitch Meesawat; Anan Kruesubthaworn; Chaiyapong Ruangsuwan; Wilawan Weera-Archakul
Journal:  Biochem Biophys Rep       Date:  2022-06-04

2.  Enhanced efficacy of photodynamic therapy by inhibiting ABCG2 in colon cancers.

Authors:  Ju Hee Kim; Jae Myung Park; Yoon Jin Roh; In-Wook Kim; Tayyaba Hasan; Myung-Gyu Choi
Journal:  BMC Cancer       Date:  2015-07-07       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.